Literature DB >> 29976686

Enhancement Strategies for Cardiac Regenerative Cell Therapy: Focus on Adult Stem Cells.

Kathleen M Broughton1, Mark A Sussman2.   

Abstract

The idiom heart of the matter refers to the focal point within a topic and, with regard to health and longevity, the heart is truly pivotal for quality of life. Societal trends worldwide continue toward increased percent body fat and decreased physical activity with coincident increases in chronic diseases including cardiovascular disease as the top global cause of death along with insulin resistance, accelerated aging, cancer. Although long-term survival rates for cardiovascular disease patients are grim, intense research efforts continue to improve both prevention and treatment options. Pharmacological interventions remain the predominant interventional strategy for mitigating progression and managing symptoms, but cellular therapies have the potential to cure or even mediate remission of cardiovascular disease. Adult stem cells are the most studied cellular therapy in both preclinical and clinical investigation. This review will focus on the advanced therapeutic strategies to augment products and methods of delivery, which many think heralds the future of clinical investigations. Advanced preclinical strategies using adult stem cells are examined to promote synergism between preclinical and clinical research, streamline implementation, and improve this imminent matter of the heart.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  adult stem cells; cardiovascular disease; cell therapy; heart failure

Mesh:

Year:  2018        PMID: 29976686      PMCID: PMC6192710          DOI: 10.1161/CIRCRESAHA.118.311207

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  94 in total

1.  Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair.

Authors:  Georgina M Ellison; Carla Vicinanza; Andrew J Smith; Iolanda Aquila; Angelo Leone; Cheryl D Waring; Beverley J Henning; Giuliano Giuseppe Stirparo; Roberto Papait; Marzia Scarfò; Valter Agosti; Giuseppe Viglietto; Gianluigi Condorelli; Ciro Indolfi; Sergio Ottolenghi; Daniele Torella; Bernardo Nadal-Ginard
Journal:  Cell       Date:  2013-08-15       Impact factor: 41.582

2.  Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors.

Authors:  Ute Modlich; Susana Navarro; Daniela Zychlinski; Tobias Maetzig; Sabine Knoess; Martijn H Brugman; Axel Schambach; Sabine Charrier; Anne Galy; Adrian J Thrasher; Juan Bueren; Christopher Baum
Journal:  Mol Ther       Date:  2009-08-11       Impact factor: 11.454

Review 3.  Cardiac Regenerative Medicine: The Potential of a New Generation of Stem Cells.

Authors:  Elena Cambria; Julia Steiger; Julia Günter; Annina Bopp; Petra Wolint; Simon P Hoerstrup; Maximilian Y Emmert
Journal:  Transfus Med Hemother       Date:  2016-07-26       Impact factor: 3.747

Review 4.  Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.

Authors:  Sudhir H Ranganath; Oren Levy; Maneesha S Inamdar; Jeffrey M Karp
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

5.  Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells.

Authors:  Carmen Urbich; Alexandra Aicher; Christopher Heeschen; Elisabeth Dernbach; Wolf K Hofmann; Andreas M Zeiher; Stefanie Dimmeler
Journal:  J Mol Cell Cardiol       Date:  2005-09-29       Impact factor: 5.000

Review 6.  Development of gene therapy for hematopoietic stem cells using lentiviral vectors.

Authors:  N B Woods; A Ooka; S Karlsson
Journal:  Leukemia       Date:  2002-04       Impact factor: 11.528

7.  Pim kinase-dependent inhibition of c-Myc degradation.

Authors:  Y Zhang; Z Wang; X Li; N S Magnuson
Journal:  Oncogene       Date:  2008-04-28       Impact factor: 9.867

Review 8.  Empowering Adult Stem Cells for Myocardial Regeneration V2.0: Success in Small Steps.

Authors:  Kathleen M Broughton; Mark A Sussman
Journal:  Circ Res       Date:  2016-03-04       Impact factor: 17.367

9.  Pim-1 associates with protein complexes necessary for mitosis.

Authors:  Nandini Bhattacharya; Zeping Wang; Christine Davitt; Ian F C McKenzie; Pei-Xiang Xing; Nancy S Magnuson
Journal:  Chromosoma       Date:  2002-05-15       Impact factor: 4.316

10.  Combined intramyocardial delivery of human pericytes and cardiac stem cells additively improves the healing of mouse infarcted hearts through stimulation of vascular and muscular repair.

Authors:  Elisa Avolio; Marco Meloni; Helen L Spencer; Federica Riu; Rajesh Katare; Giuseppe Mangialardi; Atsuhiko Oikawa; Iker Rodriguez-Arabaolaza; Zexu Dang; Kathryn Mitchell; Carlotta Reni; Valeria V Alvino; Jonathan Rowlinson; Ugolini Livi; Daniela Cesselli; Gianni Angelini; Costanza Emanueli; Antonio P Beltrami; Paolo Madeddu
Journal:  Circ Res       Date:  2015-03-23       Impact factor: 17.367

View more
  9 in total

Review 1.  Therapeutic potential of menstrual blood-derived endometrial stem cells in cardiac diseases.

Authors:  Yanli Liu; Rongcheng Niu; Wenzhong Li; Juntang Lin; Christof Stamm; Gustav Steinhoff; Nan Ma
Journal:  Cell Mol Life Sci       Date:  2019-02-05       Impact factor: 9.261

Review 2.  Cardiac regenerative therapy: Many paths to repair.

Authors:  Natalie A Gude; Mark A Sussman
Journal:  Trends Cardiovasc Med       Date:  2019-09-02       Impact factor: 6.677

Review 3.  The Progression of Regenerative Medicine and its Impact on Therapy Translation.

Authors:  Erik Jacques; Erik J Suuronen
Journal:  Clin Transl Sci       Date:  2020-02-06       Impact factor: 4.689

Review 4.  Adipose Stem Cell Translational Applications: From Bench-to-Bedside.

Authors:  Chiara Argentati; Francesco Morena; Martina Bazzucchi; Ilaria Armentano; Carla Emiliani; Sabata Martino
Journal:  Int J Mol Sci       Date:  2018-11-05       Impact factor: 5.923

5.  Extracellular vesicles from anoxia preconditioned mesenchymal stem cells alleviate myocardial ischemia/reperfusion injury.

Authors:  Chengyu Mao; Dongjiu Li; En Zhou; Erhe Gao; Tiantian Zhang; Shufang Sun; Lin Gao; Yuqi Fan; Changqian Wang
Journal:  Aging (Albany NY)       Date:  2021-02-12       Impact factor: 5.682

6.  Extracellular vesicles from hypoxia-preconditioned mesenchymal stem cells alleviates myocardial injury by targeting thioredoxin-interacting protein-mediated hypoxia-inducible factor-1α pathway.

Authors:  Cheng-Yu Mao; Tian-Tian Zhang; Dong-Jiu Li; En Zhou; Yu-Qi Fan; Qing He; Chang-Qian Wang; Jun-Feng Zhang
Journal:  World J Stem Cells       Date:  2022-02-26       Impact factor: 5.326

7.  Hypoxia-challenged MSC-derived exosomes deliver miR-210 to attenuate post-infarction cardiac apoptosis.

Authors:  Hao Cheng; Shufu Chang; Rende Xu; Lu Chen; Xiaoyue Song; Jian Wu; Juying Qian; Yunzeng Zou; Jianying Ma
Journal:  Stem Cell Res Ther       Date:  2020-06-08       Impact factor: 6.832

Review 8.  Preconditioned and Genetically Modified Stem Cells for Myocardial Infarction Treatment.

Authors:  Kamila Raziyeva; Aiganym Smagulova; Yevgeniy Kim; Saltanat Smagul; Ayan Nurkesh; Arman Saparov
Journal:  Int J Mol Sci       Date:  2020-10-02       Impact factor: 5.923

9.  Cell therapy for nonischemic dilated cardiomyopathy: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Avnish Tripathi; Mohammad Saud Khan; Abdur Rahman Khan; Vida M Vaughn; Roberto Bolli
Journal:  Stem Cells Transl Med       Date:  2021-08-04       Impact factor: 6.940

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.